Plain-English translation of NCT07570212 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Parkinson's Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing individualized transcranial magnetic stimulation (TMS)—a procedure that uses magnetic pulses to stimulate specific areas of the brain—to see if it can improve both movement problems and other symptoms in people with Parkinson's disease and related movement disorders. Researchers want to understand which symptoms respond best to this treatment and how much improvement is possible. The procedure is non-invasive, meaning nothing is inserted into your body.
Current medications and therapies don't work equally well for everyone with Parkinson's disease and related conditions, and many people continue to struggle with symptoms that affect their daily life. Researchers are exploring this treatment because early evidence suggests that targeted brain stimulation might help improve symptoms that don't respond well to other treatments.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll first undergo screening with clinical assessments, an MRI scan, and an EEG test. Then you'll receive 10 days of treatment (Monday through Friday) where you visit the clinic each day for 3–4 hours to receive the brain stimulation procedure. Throughout the study, you'll keep taking your regular medications and continue any rehabilitation you're doing. Finally, you'll have follow-up visits at the end of treatment and again 10 weeks later, with additional assessments to see how you're doing.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
China